GM01982
LCL from B-Lymphocyte
Description:
MENKES SYNDROME
ATPASE, CU(2+)-TRANSPORTING, ALPHA POLYPEPTIDE; ATP7A
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of Metal Metabolism |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization - other
|
ISCN
|
46,XY
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase Isoenzyme Electrophoresis and by Chromosome Analysis |
|
GENE MAPPING & DOSAGE STUDIES - Y CHROMOSOME |
PCR analysis of DNA from this cell culture gave a positive result with a primer for Yq11, DYS227. |
|
MNK GENE; MENKES SYNDROME |
Das et al (Am J Hum Genet 55:883-889,1994) reported that fibroblasts from this Menkes syndrome patient showed a five bp deletion, ATCTT, from nucleotide 803-807 in the MNK gene. The mutation results in a frameshift after Leu-219 and decreased level of mRNA detected by northern blot analysis. |
|
Gene |
ATP7A |
Chromosomal Location |
Xq21.1 |
Allelic Variant 1 |
fs Leu219; MENKES DISEASE |
Identified Mutation |
803_807delATCTC |
Remarks |
See GM01981 Fibroblast; 46,XY; fibroblasts show elevated copper concentration; donor subject has a 5 bp deletion at nucleotide 803 in exon 4 of the ATP7A gene (803_807delATCTC) causing a frameshift after Leu219 |
Petrovic N, Comi A, Ettinger MJ, Copper incorporation into superoxide dismutase in Menkes lymphoblasts. J Biol Chem271:28335-40 1996 |
PubMed ID: 8910456 |
|
Das S, Levinson B, Whitney S, Vulpe C, Packman S, Gitschier J, Diverse mutations in patients with Menkes disease often lead to exon skipping. Am J Hum Genet55:883-889 1994 |
PubMed ID: 7977350 |
Split Ratio |
1:5 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
20% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|